Cargando…

Mechanical Dilution of Beta-amyloid Peptide and Phosphorylated Tau Protein in Alzheimer's Disease: Too Simple to be True?

The neuropathology of Alzheimer's disease (AD) is characterized by the widespread accumulation of neuritic plaques and neurofibrillary tangles composed of deposits of beta-amyloid peptide (Aβ) and abnormally phosphorylated tau protein (phospho-tau) respectively. Considerable effort has been exp...

Descripción completa

Detalles Bibliográficos
Autor principal:	Menéndez González, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2017
Materias:	Neurosurgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370200/ https://www.ncbi.nlm.nih.gov/pubmed/28382239 http://dx.doi.org/10.7759/cureus.1062

Ejemplares similares

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
por: den Haan, Jurre, et al.
Publicado: (2018)

Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
por: Roda, Alejandro R., et al.
Publicado: (2022)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
por: Reddy, P. Hemachandra, et al.
Publicado: (2019)

Implantable Systems for Continuous Liquorpheresis and CSF Replacement
por: Menéndez González, Manuel
Publicado: (2017)

Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer’s disease
por: An, Seong Soo A., et al.
Publicado: (2023)

True Angina Pectoris Immediately After Cervical Disc Herniation Surgery for Preoperative Cervical Angina Symptoms: A Case Report
por: Abe, Takashi, et al.
Publicado: (2022)

Amyloid-beta peptide and phosphorylated tau in the frontopolar cerebral cortex and in the cerebellum of toothed whales: aging versus hypoxia
por: Sacchini, Simona, et al.
Publicado: (2020)

A Simple Modified Technique for Frameless Brain Lesion Biopsy
por: Al-Saiari, Sultan, et al.
Publicado: (2020)

Cerebrospinal Fluid Total Tau is Increased in Normal Pressure Hydrocephalus Patients who Undergo Successful Lumbar Drain Trials
por: Baird, Geoffrey, et al.
Publicado: (2017)

Heat shock proteins in the therapy of autoimmune diseases: too simple to be true?
por: Tukaj, Stefan, et al.
Publicado: (2019)

Simple Wound Closure for Civilian Cranial Gunshot Wounds: A Systematic Literature Review
por: Krueger, Evan M, et al.
Publicado: (2022)

Surgical Treatment of Far Lateral Lumbar Disc Herniation: Outcomes of the Safe and Simple Midline Approach
por: Kaya, Mustafa, et al.
Publicado: (2022)

The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer’s Disease
por: Yin, Xiaomin, et al.
Publicado: (2021)

Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays
por: van Harten, Argonde C., et al.
Publicado: (2021)

Ventricular volume in relation to lumbar CSF levels of amyloid-β 1–42, tau and phosphorylated tau in iNPH, is there a dilution effect?
por: Lidén, Simon, et al.
Publicado: (2022)

A Review of Glymphatics and the Impact of Osteopathic Manipulative Treatment in Alzheimer's Disease, Concussions, and Beyond
por: Marino, Maxwell A, et al.
Publicado: (2022)

Phosphorylation of amyloid beta (Aβ) peptides – A trigger for formation of toxic aggregates in Alzheimer's disease
por: Kumar, Sathish, et al.
Publicado: (2011)

Neurobiological pathways to Alzheimer’s disease: Amyloid-beta, TAU protein or both?
por: de Paula, Vanessa de Jesus R., et al.
Publicado: (2009)

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Shen, Xue-Ning, et al.
Publicado: (2021)

SUN-285 Too Big to Be True, Too Young to Stroke!
por: Jalil, Fatima, et al.
Publicado: (2020)

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
por: Cheignon, C., et al.
Publicado: (2017)

Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer’s disease
por: Lambracht-Washington, Doris, et al.
Publicado: (2013)

Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer’s Disease
por: Lee, Ni-Chung, et al.
Publicado: (2017)

Whole-brain modeling of the differential influences of amyloid-beta and tau in Alzheimer’s disease
por: Patow, Gustavo, et al.
Publicado: (2023)

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2023)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

Palliative Care: Too Good to Be True?
por: Senderovich, Helen, et al.
Publicado: (2020)

Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus
por: Ali, Tahir, et al.
Publicado: (2015)

Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease
por: Menendez-Gonzalez, Manuel, et al.
Publicado: (2018)

Pseudo-acetylation of multiple sites on human Tau proteins alters Tau phosphorylation and microtubule binding, and ameliorates amyloid beta toxicity
por: Gorsky, Marianna Karina, et al.
Publicado: (2017)

Oxidation of Methionine-35 in Alzheimer’s amyloid-beta peptide and the aggregation of the oxidized peptide
por: Friedemann, Merlin, et al.
Publicado: (2015)

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
por: Mullins, Roger J., et al.
Publicado: (2017)

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
por: Lue, Lih-Fen, et al.
Publicado: (2017)

JBPOS0101 regulates amyloid beta, tau, and glial cells in an Alzheimer’s disease model
por: Jeong, Jihoon, et al.
Publicado: (2020)

The Correlations Between Plasma Fibrinogen With Amyloid-Beta and Tau Levels in Patients With Alzheimer’s Disease
por: Fan, Dong-Yu, et al.
Publicado: (2021)

Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer’s Disease Associated with Down Syndrome
por: Ichimata, Shojiro, et al.
Publicado: (2023)

Electrochemical Immunosensors Developed for Amyloid-Beta and Tau Proteins, Leading Biomarkers of Alzheimer’s Disease
por: Sharma, Abhinav, et al.
Publicado: (2023)

Structure modeling and dynamics driven mutation and phosphorylation analysis of Beta-amyloid peptides
por: Singh, Sunil kumar, et al.
Publicado: (2014)

Therapeutic hypothermia, still “too cool to be true?”
por: Gibson, Alistair, et al.
Publicado: (2013)

Commentary: If it looks too good to be true, it probably is
por: Sellke, Frank W.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_innl3fsl1fhicvd5egkdlk5k6j